405 related articles for article (PubMed ID: 29856065)
1. Isoform-specific effects of transforming growth factor β on endothelial-to-mesenchymal transition.
Sabbineni H; Verma A; Somanath PR
J Cell Physiol; 2018 Nov; 233(11):8418-8428. PubMed ID: 29856065
[TBL] [Abstract][Full Text] [Related]
2. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer.
Nilsson E; Doraiswamy V; Parrott JA; Skinner MK
Mol Cell Endocrinol; 2001 Sep; 182(2):145-55. PubMed ID: 11514049
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-dependent epithelial-mesenchymal transition of tumor cells: exclusive roles of transforming growth factor β1 and β2.
Kimura C; Hayashi M; Mizuno Y; Oike M
Biochim Biophys Acta; 2013 Oct; 1830(10):4470-81. PubMed ID: 23668958
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of hypoxia on early endothelial-mesenchymal transition response to transforming growth beta isoforms 1 and 2.
Doerr M; Morrison J; Bergeron L; Coomber BL; Viloria-Petit A
Microvasc Res; 2016 Nov; 108():48-63. PubMed ID: 27503671
[TBL] [Abstract][Full Text] [Related]
5. Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter.
Song S; Zhang R; Cao W; Fang G; Yu Y; Wan Y; Wang C; Li Y; Wang Q
J Cell Physiol; 2019 Jun; 234(6):9052-9064. PubMed ID: 30378114
[TBL] [Abstract][Full Text] [Related]
6. IL-1β and TGFβ2 synergistically induce endothelial to mesenchymal transition in an NFκB-dependent manner.
Maleszewska M; Moonen JR; Huijkman N; van de Sluis B; Krenning G; Harmsen MC
Immunobiology; 2013 Apr; 218(4):443-54. PubMed ID: 22739237
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of in situ and plasma levels of transforming growth factor β1, -2 and -3 in cutaneous melanoma.
Tang MR; Wang YX; Guo S; Han SY; Li HH; Jin SF
Mol Med Rep; 2015 Jun; 11(6):4508-12. PubMed ID: 25625662
[TBL] [Abstract][Full Text] [Related]
8. FGF2 inhibits endothelial-mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-β signaling.
Correia AC; Moonen JR; Brinker MG; Krenning G
J Cell Sci; 2016 Feb; 129(3):569-79. PubMed ID: 26729221
[TBL] [Abstract][Full Text] [Related]
9. TGFβ2 and TGFβ3 isoforms drive fibrotic disease pathogenesis.
Sun T; Huang Z; Liang WC; Yin J; Lin WY; Wu J; Vernes JM; Lutman J; Caplazi P; Jeet S; Wong T; Wong M; DePianto DJ; Morshead KB; Sun KH; Modrusan Z; Vander Heiden JA; Abbas AR; Zhang H; Xu M; N'Diaye EN; Roose-Girma M; Wolters PJ; Yadav R; Sukumaran S; Ghilardi N; Corpuz R; Emson C; Meng YG; Ramalingam TR; Lupardus P; Brightbill HD; Seshasayee D; Wu Y; Arron JR
Sci Transl Med; 2021 Aug; 13(605):. PubMed ID: 34349032
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of Tgfbeta1-3 associate with myocardialisation of the outflow tract and the development of the epicardium and the fibrous heart skeleton.
Molin DG; Bartram U; Van der Heiden K; Van Iperen L; Speer CP; Hierck BP; Poelmann RE; Gittenberger-de-Groot AC
Dev Dyn; 2003 Jul; 227(3):431-44. PubMed ID: 12815630
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of TGFβ isoforms in breast cancer highlights different roles during breast cancer progression.
Hachim MY; Hachim IY; Dai M; Ali S; Lebrun JJ
Tumour Biol; 2018 Jan; 40(1):1010428317748254. PubMed ID: 29320969
[TBL] [Abstract][Full Text] [Related]
12. TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
Vagenas K; Spyropoulos C; Gavala V; Tsamandas AC
J Surg Res; 2007 May; 139(2):182-8. PubMed ID: 17270215
[TBL] [Abstract][Full Text] [Related]
13. Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells.
Kokudo T; Suzuki Y; Yoshimatsu Y; Yamazaki T; Watabe T; Miyazono K
J Cell Sci; 2008 Oct; 121(Pt 20):3317-24. PubMed ID: 18796538
[TBL] [Abstract][Full Text] [Related]
14. ALK-1 to ALK-5 ratio dictated by the Akt1-β-catenin pathway regulates TGFβ-induced endothelial-to-mesenchymal transition.
Verma A; Artham S; Somanath PR
Gene; 2021 Feb; 768():145293. PubMed ID: 33157202
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-β2 promotes Snail-mediated endothelial-mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling.
Medici D; Potenta S; Kalluri R
Biochem J; 2011 Aug; 437(3):515-20. PubMed ID: 21585337
[TBL] [Abstract][Full Text] [Related]
16. MFGE8 is down-regulated in cardiac fibrosis and attenuates endothelial-mesenchymal transition through Smad2/3-Snail signalling pathway.
Wang B; Ge Z; Wu Y; Zha Y; Zhang X; Yan Y; Xie Y
J Cell Mol Med; 2020 Nov; 24(21):12799-12812. PubMed ID: 32945126
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A1 Inhibits the TGF-β1-Induced Endothelial-to-Mesenchymal Transition of Human Coronary Artery Endothelial Cells.
Feng J; Zhang J; Jackson AO; Zhu X; Chen H; Chen W; Gui Q; Yin K
Cardiology; 2017; 137(3):179-187. PubMed ID: 28434000
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase 3 unconventional splicing mediates endothelial-to-mesenchymal transition through transforming growth factor β2.
Zeng L; Wang G; Ummarino D; Margariti A; Xu Q; Xiao Q; Wang W; Zhang Z; Yin X; Mayr M; Cockerill G; Li JY; Chien S; Hu Y; Xu Q
J Biol Chem; 2013 Nov; 288(44):31853-66. PubMed ID: 24045946
[TBL] [Abstract][Full Text] [Related]
19. Distinct effects of pharmacological inhibition of stromelysin1 on endothelial-to-mesenchymal transition and myofibroblast differentiation.
Alharthi A; Verma A; Sabbineni H; Adil MS; Somanath PR
J Cell Physiol; 2021 Jul; 236(7):5147-5161. PubMed ID: 33319933
[TBL] [Abstract][Full Text] [Related]
20. Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, and TGFbeta3) during embryonic rat testis development.
Cupp AS; Kim G; Skinner MK
Biol Reprod; 1999 Jun; 60(6):1304-13. PubMed ID: 10330085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
